Your browser doesn't support javascript.
loading
N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm.
Nieminen, Heini; Nummela, Pirjo; Satomaa, Tero; Heiskanen, Annamari; Hiltunen, Jukka O; Kaprio, Tuomas; Seppänen, Hanna; Hagström, Jaana; Mustonen, Harri; Ristimäki, Ari; Haglund, Caj.
Afiliación
  • Nieminen H; Department of Surgery, University of Helsinki and Helsinki University Hospital, P.O. Box 440, 00029, Helsinki, Finland. heini.nieminen@hus.fi.
  • Nummela P; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Satomaa T; Glykos Finland Ltd, Helsinki, Finland.
  • Heiskanen A; Glykos Finland Ltd, Helsinki, Finland.
  • Hiltunen JO; Glykos Finland Ltd, Helsinki, Finland.
  • Kaprio T; Department of Surgery, University of Helsinki and Helsinki University Hospital, P.O. Box 440, 00029, Helsinki, Finland.
  • Seppänen H; Research Programs Unit, Translational Cancer Medicine Research Program, University of Helsinki, Helsinki, Finland.
  • Hagström J; Department of Surgery, University of Helsinki and Helsinki University Hospital, P.O. Box 440, 00029, Helsinki, Finland.
  • Mustonen H; Research Programs Unit, Translational Cancer Medicine Research Program, University of Helsinki, Helsinki, Finland.
  • Ristimäki A; Department of Pathology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Haglund C; Departmentof Oral Pathology and Radiology, University of Turku, Turku, Finland.
Sci Rep ; 13(1): 13191, 2023 08 14.
Article en En | MEDLINE | ID: mdl-37580349
Intraductal papillary mucinous neoplasms (IPMNs), often found incidentally, are potentially malignant cystic tumors of the pancreas. Due to the precancerous nature, IPMNs lacking malignant features should be kept on surveillance. The follow-up relies on magnetic resonance imaging, which has a limited accuracy to define the high-risk patients. New diagnostic methods are thus needed to recognize IPMNs with malignant potential. Here, aberrantly expressed glycans constitute a promising new area of research. We compared the N-glycan profiles of non-invasive IPMN tissues (n = 10) and invasive IPMN tissues (n = 10) to those of non-neoplastic pancreatic controls (n = 5) by matrix-assisted laser desorption-ionization time-of-flight (MALDI-TOF) mass spectrometry. Both IPMN subgroups showed increased abundance of neutral composition H4N4 and decrease in H3N5F1, increase in sialylation, and decrease in sulfation, as compared to the controls. Furthermore, invasive IPMN showed an increase in terminal N-acetylhexosamine containing structure H4N5, and increase in acidic complex-type glycans, but decrease in their complex fucosylation and sulfation, as compared to the controls. In conclusion, the N-glycan profiles differed between healthy pancreatic tissue and non-invasive and invasive IPMNs. The unique glycans expressed in invasive IPMNs may offer interesting new options for diagnostics.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Mucinoso / Carcinoma Ductal Pancreático / Neoplasias Intraductales Pancreáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Mucinoso / Carcinoma Ductal Pancreático / Neoplasias Intraductales Pancreáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido